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Summary
Objective: Development and remodeling of engineered cartilage-explant composites were studied in vitro and in vivo.
Design: Individual and interactive effects of cell chondrogenic potential (primary or ﬁfth passage bovine calf chondrocytes), scaffold
degradation rate (hyaluronan benzyl ester or polyglycolic acid), and adjacent tissue cell activity and architecture (vital trabecular bone (VB),
articular cartilage (AC), devitalized bone (DB) or digested cartilage (DC)) were evaluated over 8 weeks in vitro (bioreactor cultures) and in vivo
(ectopic implants).
Results: In vitro, signiﬁcant effects of cell type on construct adhesive strength (P! 0.001) and scaffold type on adhesive strength (P! 0.001),
modulus (PZ 0.014), glycosaminoglycans (GAG) (P! 0.001), and collagen (PZ 0.039) were observed. Chondrogenesis was best when the
scaffold degradation rate matched the extracellular matrix deposition rate. In vivo, adjacent tissue type affected adhesive strength (P! 0.001),
modulus (P! 0.001), and GAG (P! 0.001) such that 8-week values obtained for bone (VB and DB) were higher than for cartilage (AC). In the
AC/construct group, chondrogenesis appeared attenuated in the region of the construct close to the AC. In contrast, in the VB/construct group,
a 500 mm thick zone of mature hyaline-like cartilage formed at the interface, and signs of active remodeling were present in the bone that
included osteoclastic and osteoblastic activity and trabecular rebuttressing; these features were not present in the DB group or in vitro.
Conclusions: Development and remodeling of composites based on engineered cartilage were mediated in vitro by cell chondrogenic potential
and scaffold degradation rate, and in vivo by type of adjacent tissue and time.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyIntroduction
Osteochondral defect repair remains an important, un-
solved clinical problem, and a number of tissue engineering
approaches involving cells and biomaterial scaffolds have
been studied in an attempt to promote articular cartilage
(AC) regeneration1,2. However, the most commonly used
animal model, orthotopic implants in rabbit knee joints, is
complicated by high variability and a fundamentally different
biological situation from that existing in human joint
lesions2,3. To address the problem of biological complexity,
controlled in vitro studies have been done in petri dishes4e7
and bioreactors8,9. Complementary in vivo data have also
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nude mice10e15.
In the present study, in vitro (bioreactor) and in vivo
(ectopic implant) models were utilized to explore the
hypotheses that development and remodeling in compo-
sites made of engineered cartilage constructs and bone or
cartilage explants depended on: (i) chondrogenic potential
of the cell in the construct, (ii) scaffold degradation rate, (iii)
adjacent tissue cell activity and architecture, and (iv) time
(Fig. 1). We compared two cell types: primary (P0) calf
chondrocytes that were expected to undergo rapid chondro-
genesis16,17 and ﬁfth passage (P5) chondrocytes that were
expected be dedifferentiated by serial expansion in mono-
layers using media containing 10% serum18,19. We com-
pared two scaffolds: hyaluronan benzyl ester (Hyaff11)
that was expected to degrade only minimally over 8
weeks9,20 and a structurally indistinguishable scaffold made
of polyglycolic acid (PGA) that was expected to be almost
completely degraded over 8 weeks21,22.
We compared four different adjacent tissues: AC and vital
trabecular bone, (VB), to represent the range of tissues
involved in osteochondral defect repair1, devitalized bone
(DB) to explore whether bone cells or architecture
inﬂuenced integration9, and digested cartilage (DC) in an6
897Osteoarthritis and Cartilage Vol. 13, No. 10Histology
• hematoxylin/eosin
• safranin O/fast green
• collagen type I or II Biomechanics 
• Adhesive Strength
push-through   or   tensile test 
• Modulus
confined compression test
Load
Disp.
Time
Time
Load
Disp.
Time
Time
Composite
+or
Chondrocytes
P0 (primary)
P5 (passsaged)
Scaffold
Hyaff®11 (hyaluronan ester)
PGA (polyglycolic acid)
Construct:
VB (vital bone)
AC (articular cartilage)
DB (devitalized bone)
DC (digested cartilage)
Adjacent tissue:
• glycosaminoglycans
• collagen (total)
• DNA (cells)
Composition
Fig. 1. Experimental design. Composites were generated using explanted adjacent tissues (VB, AC, DB, or DC) and constructs made of
chondrocytes (P0 or P5) and biomaterial scaffolds (Hyaff11 or PGA). Disc-in-ring composites made by press-ﬁtting discs (5! 2 mm) into
rings (10/5 mm! 2 mm) were cultured in rotating bioreactors. Sandwich-like composites made by suturing together two discs (8! 2 mm)
were implanted subcutaneously in nude mice. Histology, biomechanics, and biochemical composition were evaluated after 4 and 8 weeks.attempt to enhance integration by depletion of surface
glycosaminoglycans (GAG)8,23 in the explants. We evalu-
ated composite histological structure, biomechanical prop-
erties, and biochemical composition after 4 and 8 weeks.
Methods
EXPERIMENTAL DESIGN
Twelve experimental groups were studied, each of which
provided speciﬁc controls for other groups as follows. Based
on our previous study9, three basic groups were evaluated in
vitro and in vivo; AC/P0/Hyaff11, VB/P0/Hyaff11, and DB/
P0/Hyaff11. In vitro we also studied AC/P5/Hyaff11
composites, where dedifferentiated P5 cells provided a con-
trol for more chondrogenic P0 cells, and AC/P0/PGA
composites, where quickly degradingPGAprovided a control
for more slowly degrading Hyaff11. In vitro we also studied
individually cultured specimens of VBandDB that, in contrast
to AC24, had not previously been cultured in rotating
bioreactors. In vivo, we also studied DC/P0/Hyaff11
composites, where DC was expected to provide a more
adhesive substrate than AC25 and VB/AC composites which
provided an explant/explant control group.
CONSTRUCTS
Chondrocytes were obtained from full thickness cartil-
age harvested from the femoropatellar groove (FPG) of
2e4-week-old bovine calves within 8 h of slaughter21. TheP0 cells were seeded onto scaffolds immediately after
isolation, whereas the P5 cells were seeded onto scaffolds
after ﬁve serial passages in monolayers plated at low initial
density (10,000 cells/cm2). All cells were cultured in
Dulbecco’s modiﬁed Eagle medium (DMEM) containing
4.5 g/L glucose, 10% fetal bovine serum (FBS), 10 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
0.1 mM nonessential amino acids, 0.4 mM proline, 50 mg/L
L-ascorbic acid, 100 U/mL penicillin, 100 mg/mL streptomy-
cin, and 0.5 mg/mL fungizone21.
The Hyaff11 and PGA scaffolds, respectively obtained
from Fidia Advanced Biopolymers (Abano Terme, IT) and
Smith & Nephew (York, UK), were formed as non-woven
meshes that were indistinguishable with respect to three-
dimensional structure17. The Hyaff11 had a weight aver-
aged molecular weight (Mw) of 168 kDa and was minimally
degraded over 8 weeks9,20,26, whereas the PGA had a Mw
of 69 kDa and was essentially degraded over 8 weeks22.
The scaffolds were wetted in FBS for 1e2 h, vacuum-dried,
die-punched into discs, and seeded with cells for a period of
3 days in spinner ﬂasks9, using 60 million cells, 10 scaffolds
(6! 2 mm discs), and 150 mL per ﬂask for in vitro studies,
or 80 million cells, 10 scaffolds (8! 2 mm discs), and
180 mL per ﬂask for in vivo studies.
EXPLANTS
Osteochondral cores (10 and 8 mm in diameter for in vitro
and in vivo studies, respectively) were obtained from the
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week-old calves. A razor blade was ﬁrst used to remove the
uppermost 1 mm regions of cartilage (articular surface) or
bone (subchondral plate), and then to make ﬂat, 2 mm thick
discs of AC or VB. To prepare DB type 2, discs of VB were
extensively rinsed with distilled water (1 week) and
lyophilized (3 days)9. To prepare DC, discs of AC were
digested ﬁrst for 16 h at 37(C in 0.01% (30 U/mL)
collagenase type 2 (Worthington) containing 5% FBS in
DMEM, then for 5 min at 37(C in 1 U/mL chondroitinase
ABC (Seikagaku, Tokyo) in 10 mM TriseHCl buffer25. Prior
to composite preparation, AC discs were stored in DMEM
for 24 h at 4(C, VB discs were cultured in DMEM for 16 h at
37(C, DB was stored dry at 20(C, and DC was rinsed
and used immediately. Explants from a total of 24 different
knee joints were used in six independent studies.
IN VITRO STUDIES
To make discering composites, a construct disc
(5! 2 mm)was die-punched and press-ﬁtted into a cartilage
or bone ring (10/5! 2e3 mm). After 7 days in orbitally mixed
petri dishes, composites were placed in rotating bioreactors
(RCCV 110, Synthecon, Houston) and maintained freely
suspended by adjusting the rotation speed to 35e45 rpm8,9.
Media were replaced two to three times per week and
composites were sampled after 4 and 8 weeks. A total of 130
composites were cultured in a total of 13 bioreactors.
IN VIVO STUDIES
To make sandwich-like composites, a construct disc
(8! 2 mm) was sutured to a cartilage or bone disc
(8! 2e3 mm) using resorbable 5.0 Vicryl (polyglycolide-
co-lactide 90/10, Ethicon)27. The suture was wrapped
around the two discs, knotted, wrapped around the
composite in an orientation perpendicular to the ﬁrst wrap,
and again knotted. After 5e7 days in orbitally mixed petri
dishes, composites were implanted in nude mice (National
Institutes of Health (NIH) nu/nu, 8 week old, 25 g, Charles
River) according to a protocol approved by an Animal Care
and Use Committee. Anesthesia was induced and main-
tained using isoﬂuorane (2e3%) and oxygen (1 L/min)
supplied with a device made for rodents (IMPAC6,
VetEquip, Pleasanton) and administered by nasal cone.
Composites were rinsed with phosphate buffered saline
(PBS) and inserted into individual subcutaneous pouches,
positioned such that the explant faced the dorsal muscu-
lature and the construct faced the skin. Composites were
sampled after 3 days, 4 weeks, and 8 weeks. A total of 115
composites were implanted in 31 mice.
HISTOLOGICAL ANALYSES
Representative composites (two per data point) were
ﬁxed in 10% neutral buffered formalin for 24 h at room
temperature (RT). Composites with AC or DC rings were
transferred to 70% ethanol, whereas composites containing
VB or DB rings were ﬁrst decalciﬁed using acidic decalciﬁer
(RDO, Apex) and then placed in 70% ethanol9. Samples
were embedded in parafﬁn, sectioned to 5 mm, stained with
hematoxylin and eosin or safranin-O/fast green, and
immunostained with monoclonal antibodies against bovine
collagen types I and II17.BIOMECHANICAL ANALYSES
Representative composites (ﬁve to six per data point)
were used to determine adhesive strength. First, ﬁbrous
surface capsules were removed in order to minimize
artifacts7. Capsules were removed from in vitro-grown
disc-in-ring composites by carefully shaving off the top and
bottom surfaces using a microtome blade and specimen
holding device9. The shaved sample was secured in a push-
through device connected to a Electro-Force test system
(ELF-3200, Bose, Framingham, MA) ﬁtted with a 50 lb load
cell, and compression (0.5 mm/min) was applied to the disc
until it was displaced from the ring9. To facilitate capsule
removal, we changed composite geometry for the sub-
sequent in vivo studies, even though the change precluded
direct comparison of adhesive strength data obtained in vitro
and in vivo. The use of sandwich-like composites permitted
efﬁcient and reproducible preparation of a capsule-free
composite by cutting an 8 mm diameter, 5e6 mm thick
discoid sandwich into a 6! 6! 5e6 mm cuboid sandwich.
The cuboid sandwich was secured in a custom-built testing
device connected to an Instron (Model 5542, Canton, MA)
ﬁtted with a 500 N load cell, and tension (0.5 mm/min) was
applied to one part of the device until it was displaced from
a complementary part of the device. Each of the two
complementary parts of the device had a square pocket
(6! 6! 4 mm) into which the engineered construct or
explanted tissue component of the sandwich could be
secured. Spacers were inserted as needed below the
construct and explant to align the interface of the sandwich
with the interface of the device, which was made of highly
polished aluminum to facilitate distraction. Data obtained
from push-through and tensile tests were consistent with
composite failure at the construct-tissue interface. In
particular, load-displacement proﬁles showed a single,
distinct peak after which the load decreased gradually to
zero, consistent with interfacial fracture propagation4 and
complete removal of the surface capsule7. Construct
adhesive strength was calculated as the measure of the
ultimate load divided by the original overlap area.
Compressive modulus was assessed after adhesive
strength testing, i.e., on constructs that appeared macro-
scopically intact but may have incurred molecular-level
alterations. Constructs (ﬁve to six per data point) were
equilibrated in PBS for 10 min at RT and placed in a chamber
custom-designed to provide radial conﬁnement while permit-
ting uni-axial ﬂuid ﬂow via a stainless steel ﬁlter with 50 mm
pore size. The chamberwas ﬁlledwith PBS and connected to
the ELF-3200, using load cells of 250 g and 50 lb for in vitro
and in vivo samples, respectively. Five consecutive stress-
relaxations were applied: a 5% strain step followed by four
2% strain steps, each 600 s in duration. Constructs were
considered to be fully relaxed during this increment based on
a change in stress less than 0.009 MPa over the ﬁnal 180 s.
Data were recorded using a 10 Hz ﬁlter at an average
sampling rate of 2 points/s. Equilibrium modulus was
determined as the slope of the best linear regression ﬁt
(r2O 0.95) of equilibrium stress vs applied strain.
BIOCHEMICAL ANALYSES
Following biomechanical testing, constructs (four to six per
data point) were weighed, frozen, lyophilized, and papain-
digested21. The GAG content was measured spectrophoto-
metrically using dimethylmethylene blue dye28 and bovine
chondroitin sulfate as a standard. Total collagen content was
determined from the hydroxyproline content after acid
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and chloramine-T29, using a hydroxyproline-to-collagen ratio
of one-to-ten30. The cell content was calculated from DNA,
assessed spectroﬂuorometrically with the use of Hoechst
33258 dye and conversion factors of 7.7 pg DNA per
chondrocyte31 and 1010 g per chondrocyte22.
STATISTICAL ANALYSIS
Statistical differences between groups was determined
by multi-way analysis of variance (ANOVA) in conjunction
with Tukey’s post hoc test (Statistica Version 7, StatSoft,
Tulsa, OK). P-values below 0.05 were considered statisti-
cally signiﬁcant.
Results
IN VITRO STUDIES
Initial (3-day) constructs from all groups were comprised
of scaffold ﬁbers with attached cells (0.50G 0.06% of wet
weight, % ww), small amounts of GAG (0.25G 0.03% ww),
and low moduli (7G 1 kPa). Low moduli of initial constructs
and structural instability of the non-woven meshes implied
minimal contribution of the scaffold to ﬁnal construct
mechanical properties. Multi-way ANOVA showed a main
effect of cell type on construct adhesive strength
(P! 0.001) and interactive effects of cell type and time
on adhesive strength (P! 0.001) and GAG content
(P! 0.001) (Table I). The ANOVA also showed main
effects of scaffold type on adhesive strength (P! 0.001),
modulus (PZ 0.014), GAG (P! 0.001), collagen
(PZ 0.039), and cells (P! 0.001) and interactive effects
of scaffold type and time on GAG, collagen, and cells (Table
I). As compared to corresponding constructs in the AC/P0/
Hyaff11 group, post hoc analysis showed that constructs
made with P5 cells had lower GAG at 8 weeks, and that
constructs made with PGA scaffolds had higher adhesive
strength and GAG at 4 and 8 weeks (Table I).
In constructs cultured adjacent to AC, the extracellular
matrix (ECM) of the construct did not project into the solid
structure of the AC (Fig. 2). Constructs in the AC/P0/
Hyaff11 group were comprised of abundant scaffold
remnants and tissue that was morphologically consistent
with hyaline-like cartilage, i.e., round-to-oval chondrocytes
in a matrix that stained positive for GAG [Fig. 2(A)] and
collagen type II (not shown). In the AC/P5/Hyaff11 group,
constructs were comprised of scaffold remnants and ﬁbrous
tissue, i.e., actively dividing, spindle-shaped cells in a matrix
that did not stain positive for GAG [Fig. 2(B)] or collagen
type II, and instead stained for collagen type I (not shown).
In the AC/P0/PGA group, minimal scaffold remnants were
present and constructs were morphologically consistent
with hyaline-like cartilage [Fig. 2(C, D)]. In all groups,
a ﬁbrous capsule, 100e300 mm thick comprising spindle-
shaped cells and collagen type I, formed at the composite
surfaces [Fig. 2(D)] as previously reported in vitro7,9,24
and in vivo11,12,21.
In constructs cultured adjacent to bone (VB and DB), the
interface appeared interdigitated [Fig. 3(A, C)]. In the DB/
construct group, chondrogenesis was evident at the interface
and ﬁbrous tissue ﬁlled the intertrabecular spaces [Fig. 3(A)],
whereas individually cultured DB contained neither viable
cells nor ﬁbrous tissue [Fig. 3(B)]. The VB/construct group
exhibited chondrogenesis at the interface [Fig. 3(C)], whereasindividually culturedVB formed tissue resemblingaperiosteal
bone collar at the inner diameter of the ring [Fig. 3(D)]. In VB
rings culturedwith andwithout constructs, amixture ofwoven
bone, hyaline-like cartilage, and ﬁbrous tissue ﬁlled the
intertrabecular spaces [Fig. 3(C, D)].
IN VIVO STUDIES
Multi-way ANOVA showed main effects of adjacent tissue
type on construct adhesive strength (P! 0.001), modulus
(P! 0.001), GAG (P! 0.001) and collagen (PZ 0.023)
(Table II). ANOVA also showed main effects of time on
adhesive strength (PZ 0.032), modulus (P! 0.001) and
GAG (P! 0.001), consistent with previous reports14,15, and
interactive effects of adjacent tissue type and time (Table
II). Constructs implanted for 8 weeks adjacent to bone (VB
and DB) exhibited signiﬁcantly higher adhesive strength,
modulus, and GAG than corresponding constructs im-
planted adjacent to AC. Comparison of the VB/AC and
VB/construct groups showed signiﬁcantly higher adhesive
strength in the latter group but signiﬁcantly higher modulus,
GAG, and collagen for AC than the construct (Table II).
Comparison of average values obtained for the AC/P0/
Hyaff11 group in vitro and in vivo showed that the in vivo
model yielded constructs with approximately ﬁve-fold higher
moduli, two-fold higher GAG, and two-fold higher collagen
(Table II vs Table I).
In the VB/AC group, composites exhibited a distinct
interface, without any apparent integrative repair response
by either component [Fig. 4(B)]. The intertrabecular bone
spaces, which contained a mix of hematopoetic marrow
elements, blood clots, and adipose tissue in 3-day explants
[Fig. 4(A)], were ﬁlled mainly with adipose tissue by 4 weeks
[Fig. 4(B)]. Fracture callus repair tissue was occasionally
present in the VB, away from its interface with AC, and
blood vessels were occasionally present in the immature
calf cartilage and bone.
All constructs implanted adjacent to AC exhibited an
asymmetric pattern of chondrogenesis wherein a mix of
ﬁbrocartilaginous tissue and densely packed scaffold
remnants was present closer to the interface and more
hyaline-like cartilage developed further from the interface
with AC [Fig. 4(C, D)]. Enzymatic digestion yielded DC with
a surface layer 150 mm thick that was devoid of GAG at the
time of composite preparation, but was repleted with GAG
after 4 and 8 weeks in vivo (not shown). Samples from the
AC/construct and DC/construct groups exhibited compara-
ble biomechanical and biochemical properties (Table II).
All constructs implanted adjacent to VB were comprised
of hyaline-like cartilage [Fig. 5(A, B)]. Histology revealed
a robust integrative repair response that included an
interfacial region approximately 500 mm thick in which
chondrocytes were aligned in columns [Fig. 5(A, B)].
Evidence of active bone resorption and formation included
multinucleated osteoclasts degrading existing lamellar bone
[Fig. 5(C)] and osteoblasts aligned on the surface of
trabeculae in association with a distinctive cement line as
new osteoid was deposited on pre-existing bone [Fig. 5(D,
E)]. The intertrabecular spaces in the VB were ﬁlled with
fracture callus repair tissue close to the interface, and
adipose tissue elsewhere in explant. In the DB/construct
group, trabecular remodeling was not observed, and
construct and intertrabecular spaces were ﬁlled with
a ﬁbrocartilaginous tissue that stained positive for GAG
[Fig. 5(F)].
900 E. Tognana et al.: Osteochondral tissue remodelingFig. 2. In vitro effects of cellular chondrogenic potential and scaffold degradation rate. Histological appearance of 8-week samples of: (A) AC/
P0/Hyaff11, (B) AC/P5/Hyaff11, and (C, D) AC/P0/PGA. Representative (AeC) transverse and (D) cross-sections stained with safranin-O/
fast green. In (D), arrow points towards the AC region and arrowhead denotes ﬁbrous capsule. Scale bars: (AeC) 500 mm, (D) 250 mm, Inset to
(A) 100 mm.
Fig. 3. In vitro effects of bone viability and construct presence. Histological appearance of 8-week samples of: (A) DB/P0/Hyaff11, (B) DB, (C)
VB/P0/Hyaff11, and (D) VB. Representative sections stained with safranin-O/fast green. Scale bars: (AeD) 500 mm, Inset to (D) 200 mm.
Table I
tro
effect Interactive effect
ffold type Time (t) Cell! t Scaffold! t
0.001 NS P! 0.001 NS
0.014 NS NS NS
0.001 NS P! 0.001 PZ 0.040
0.039 NS NS PZ 0.016
0.001 NS NS PZ 0.004
in vivo
Main effect Interaction
Adjacent tissue Time (t) Adjacent tissue! t
P! 0.001 PZ 0.032 PZ 0.031
P! 0.001 P! 0.001 P! 0.001
P! 0.001 P! 0.001 NS
PZ 0.023 NS NS
9
0
1
O
s
te
o
a
rth
ritis
a
n
d
C
a
rtila
g
e
V
o
l.
1
3
,
N
o
.
1
0Effects of type of cell and scaffold on the properties of constructs cultured in vi
Property Time (weeks) Type of cell and scaffold Main
AC/P0/Hyaff AC/P5/Hyaff AC/P0/PGA Cell type Sca
Adhesive Strength (kPa) 4 66.4G 26.9 255G 41* 153G 37.6y P! 0.001 P!
8 134G 38.6 159G 45.2z 267G 62.0yz
Modulus (kPa) 4 19.5G 7.93 16.2G 13.1 39.4G 19.2 NS PZ
8 30.9G 7.58 20.6G 7.10 48.5G 32.8
GAG (% ww) 4 1.20G 0.23 1.64G 0.27 3.98G 0.71y NS P!
8 1.74G 0.27 0.38G 0.058*z 3.88G 0.13y
Collagen (% ww) 4 2.74G 0.53 3.56G 0.75 2.79G 0.59 NS PZ
8 2.36G 0.92 1.39G 0.42 4.98G 2.57yz
Cells (% ww) 4 0.911G 0.053 0.913G 0.325 0.843G 0.047 NS P!
8 1.097G 0.071 0.972G 0.120 0.631G 0.039y
Data are the averageG standard deviation of nZ 6 mechanical or biochemical samples; NS, not signiﬁcant.
*Signiﬁcantly different from the corresponding sample made with P0 cells (AC/P0/Hyaff group).
ySigniﬁcantly different from the corresponding sample made with Hyaff scaffold (AC/P0/Hyaff group).
zSigniﬁcantly different from the corresponding 4-week sample.
Table II
Effects of type of adjacent tissue and time on the properties of constructs implanted
Property Time (weeks) Type of adjacent tissue
DC/construct AC/construct DB/construct VB/construct VB/AC
Adhesive strength (kPa) 4 176G 33 173G 52 413G 95*y 398G 33*y 134G 35z
8 286G 84x 222G 62 509G 128*yx 334G 19yk 196G 104z
Modulus (kPa) 4 100G 37 94G 21 142G 58 162G 59 739G 205z
8 237G 93x 194G 53 360G 156*yx 637G 219*yxk 961G 68z
GAG (% ww) 4 3.24G 0.35 2.63G 0.26 3.60G 0.14y 3.66G 0.47y 6.30G 0.36z
8 3.75G 0.15x 3.81G 0.95 5.20G 0.91*yx 5.78G 1.16*yx 7.38G 0.92
Collagen (% ww) 4 3.52G 1.26 4.04G 0.57 5.70G 0.79* 6.06G 1.38* 10.8G 1.84z
8 4.10G 0.94 6.08G 2.02*x 4.13G 1.25 5.63G 0.58 9.52G 2.56z
Data are the averageG standard deviation of nZ 5e6 mechanical or nZ 4 biochemical analyses; NS, not signiﬁcant.
*Signiﬁcantly different from the corresponding DC sample.
ySigniﬁcantly different from the corresponding AC sample.
zSigniﬁcantly different from the VB/construct group.
xSigniﬁcantly different from the corresponding 4-week sample.
kSigniﬁcantly different from the corresponding DB sample.
902 E. Tognana et al.: Osteochondral tissue remodelingFig. 4. In vivo effects of adjacent cartilage. Histological appearance of: (A) AC/VB at 3 days (bone region), (B) AC/VB at 4 weeks (interface),
and (C, D) AC/P0/Hyaff11 at (C) 4 weeks or (D) 8 weeks. Representative sections stained with (A) hematoxylin & eosin or (BeD) safranin-O/
fast green. Scale bars: (A) 100 mm, (B, D) 500 mm, (C) 1.0 mm.Discussion
Complementary in vitro and in vivo studies of develop-
ment and remodeling in composites made of engineered
cartilage and explanted cartilage or bone demonstrated
signiﬁcant effects of cell chondrogenic potential, scaffold
degradation rate, adjacent tissue cell activity and architecture,
and time. Our ﬁndings that constructs based on P5 cells
exhibited ﬁbrous histomorphology [Fig. 2(B)] and biome-
chanical and biochemical properties that deteriorated with
time (Table I) can be attributed to cellular dedifferentiation,
a process mediated by the animal species, donor age, cell
density, and concentrations of serum and growth factors in
the culture medium32e35. Our ﬁndings underscore the need
to maintain and verify chondrogenic cell phenotype by
coupling controlled expansion conditions with molecular-
level assessment18,19,36,37.
Our ﬁnding that rapidly degrading PGA scaffolds ex-
hibited hyaline-like cartilage morphology [Fig. 2(C, D)] and
relatively high GAG (Table I) can be explained by the good
match between in vitro rates of scaffold degradation and
cartilaginous ECM deposition by P0 calf chondrocytes
cultured on PGA non-woven mesh in rotating bioreactors16.
The importance of matching in vivo rates of scaffold
degradation and osteochondral defect repair has also been
demonstrated38. However, although rapidly degrading,
polyester-based scaffolds yielded the best outcomes in
bioreactors (Table I) and rabbits38, more slowly degrading
scaffolds may be required to match the slower rates of ECM
deposition and defect repair in different models more
relevant to human AC repair13,38,39. Our ﬁndings implied
that rate of scaffold degradation was a critical variable, theappropriate selection of which in turn depended on the rates
of cell- and tissue-level repair responses speciﬁc to the
experimental model or clinical application.
In vivo, developmental chondrogenesis appeared attenu-
ated in regions of the construct that were closely apposed to
cartilage explant [Fig. 4(C)], and adhesive strength,modulus,
and GAG were all signiﬁcantly lower in the AC/construct
group than in either of the bone/construct groups (Table II).
Moreover, VB/AC composites exhibited no integrative re-
sponse from either component [Fig. 4(B)], whereas VB/
construct composites exhibited robust interfacial remodeling
[Fig. 5(AeE)]. Together, these data implied that the presence
of adjacent AC negatively affected construct development
and integrative repair in vivo. Adverse effects of AC were not
abolishedbydepletionof surfaceGAGusingamodiﬁcationof
an enzymatic technique previously shown improve cell
adhesion to AC25. Further studies are warranted to develop
methods that may improve integration by depleting speciﬁc
AC components, as previously discussed40e43.
Interestingly, in the VB/construct group we observed
repair responses similar in some respects to the fracture
callus repair tissue that forms during the healing of
a fractured bone44, including a wide central zone of
cartilaginous tissue comprising chondrocytes aligned in
columns [Fig. 5(A, B)] and rebuttressing of the trabeculae
by new bone formation on the pre-existing bone [Fig. 5(D,
E)]. The above responses were present only in the VB group
in vivo, and not the DB group in vivo [Fig. 5(F)], the VB group
in vitro [Fig. 3(C)], or the DB group in vitro [Fig. 3(A)]. Our
ﬁndings implied that the presence of adjacent VB, a rich
source of soluble factors involved in chondrogenesis45 and
903Osteoarthritis and Cartilage Vol. 13, No. 10Fig. 5. In vivo effects of adjacent bone. Histological appearance of (A, B, D, E) VB/P0-Hyaff11 at 8 weeks, (C) VB/P0/Hyaff11 at 4 weeks,
and (F) DB/P0/Hyaff11 at 8 weeks. Representative sections stained with (A, B, F) safranin-O/fast green or (CeE) hematoxylin & eosin. In (C)
arrowheads denote osteoclasts; in (D) asterisks denote osteoblasts, in (D, E) arrows point to cement lines (trabecular rebuttressing). Scale
bars: (A, F) 500 mm; (BeE) 100 mm.the remodeling of cartilage46,47 and bone44,48 positively
affected integrative repair in vivo. The data also contribute to
a growing body of literature addressing the boneecartilage
interface in osteochondral tissues, a transitional region
critically important to joint structure and function1.
In the present study, rotating bioreactor and ectopic
implant models provided complementary data to that which
can be obtained in more complex orthotopic implant models.
Our ﬁndings that construct properties (e.g., moduli, GAG)
were higher in vivo than in vitro and that certain histological
features (e.g., chondrocyte alignment, bone remodeling)
were observed only in vivo may be explained by differences
between the two models including presence and concentra-
tion of oxygen and biophysical regulatory factors, mass
transport, and mechanical environment. Together, the data
demonstrate that it may be useful to study the developmentand remodeling of engineered cartilage via coordinated
studies carried out in vivo, i.e., an environment providing
a variable mix of host-derived regulatory factors, and in vitro,
i.e., a more controlled setting in which one or several factors
can be systematically studied.
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